
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Nutr. , 07 March 2025
Sec. Nutritional Epidemiology
Volume 12 - 2025 | https://doi.org/10.3389/fnut.2025.1565317
This article is part of the Research Topic Nutrition in Cancer Patients Undergoing Targeted Therapy: From Mechanisms to Clinical Practice View all articles
Background and aims: Malnutrition is a well-recognized predictor of poor prognosis in malignancies. Recent studies suggest that the geriatric nutritional risk index (GNRI) is a more accurate determinant of prognosis in elderly patients than conventional body mass index (BMI). This study aimed to evaluate the GNRI and body composition parameters in elderly patients with intrahepatic cholangiocarcinoma (ICC) and assess their prognostic impact on long-term outcomes.
Methods: A total of 157 elderly ICC patients (aged ≥65 years) who underwent radical resection between 2009 and 2018 were retrospectively analyzed. Skeletal muscle index (SMI), muscle attenuation (MA), visceral adipose tissue index (VATI), subcutaneous adipose tissue index (SATI), and visceral-to-subcutaneous fat ratio (VSR) were quantified using computed tomography. Prognostic analyses were conducted using the Kaplan–Meier method, with adjustments using inverse probability weighting. A nomogram based on multivariate Cox regression was constructed and internally validated, comparing its prognostic accuracy with the TNM staging system.
Results: Among the body composition parameters, low SMI (sarcopenia, 56.1%), high VSR (visceral adiposity, 54.8%), and low MA (intramuscular fat deposition, 50.3%) were significantly associated with overall survival (OS) and recurrence-free survival (RFS) (all p < 0.05). Low GNRI was also a strong predictor of poor prognosis (p < 0.001). Multivariate analysis identified low GNRI (p = 0.009), sarcopenia (p = 0.020), visceral adiposity (p = 0.033), and intramuscular fat deposition (p = 0.036) as independent prognostic factors for OS and RFS. The nomogram, incorporating GNRI, SMI, VSR, MA, microvascular invasion (MVI), CA19-9 levels, and lymph node invasion, demonstrated superior prognostic performance compared to the TNM stage, with a C-index of 0.734 (OS) and 0.704 (RFS) and an AUC of 0.809 (OS) and 0.815 (RFS).
Conclusion: GNRI, sarcopenia, IMF deposition, and visceral adiposity independently predict mortality and tumor recurrence in elderly ICC patients. Body composition is a major determinant of prognosis in patients with ICC. Our nomogram based on body composition reveals superior prognostic efficacy over TNM stages.
Liver cancer remains a major global health challenge, ranking as the third leading cause of cancer-related mortality worldwide (1). Intrahepatic cholangiocarcinoma (ICC) is a subset of liver cancer, which accounts for 10–15% of the cases (1). The incidence of ICC has increased over the past decades (2), especially among adults aged more than 60 years (3). Elderly cancer patients often experience higher surgical risks, impaired recovery, and increased mortality rates, largely due to malnutrition and age-related functional decline (4). They are not only devastated by disease but also persecuted by physical function impairment called geriatric syndrome. Such a proven relationship of malnutrition has been found in patients with hepatocellular carcinoma (5) and renal cell carcinoma (6).
Body mass index (BMI), a simple anthropometric index based on height and weight, is widely used for the assessment of nutrition status. However, it is limited due to insufficient in assessing individual components of body weight such as regional fat distribution or muscle volume (5). In addition, previous studies have shown that malnourished patients may not always have a low BMI, highlighting the need for more precise nutritional markers (7). Compared to BMI, the geriatric nutritional risk index (GNRI) is a more objective index for evaluating the nutritional status of patients aged ≥65 years. Previous studies have demonstrated its prognostic value in elderly patients with prostate cancer and heart failure (8). However, its significance in elderly ICC patients remains unclear.
Beyond nutrition, body composition plays a crucial role in cancer prognosis. Sarcopenia was first defined as a characterization of the age-related loss of skeletal muscle mass in 1989 (9). In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) clinically defined sarcopenia as a disease of progressive or systemic skeletal muscle, with a prevalence of approximately 10% in men and women aged more than 60 years (10). Emerging evidence has demonstrated that sarcopenia was linked to many negative consequences, such as falls, fractures, and even poor outcomes in many pathological conditions, which significantly strain the healthcare system (11). It is characterized by progressive and generalized loss of skeletal muscle mass and function with increasing age. It is a common but underappreciated complication of various chronic diseases and malignant tumors. Beyond skeletal muscle mass and quality, body composition, particularly the amount and distribution of adipose tissue, also plays a crucial role in sarcopenia. With aging, chronic adipose tissue inflammation contributes to the redistribution of subcutaneous fat to the intra-abdominal region (visceral adipose tissue), along with the infiltration of fat into skeletal muscles (12).
Therefore, this study aimed to investigate the prognostic value of the GNRI in combination with key body composition parameters (skeletal muscle and adipose tissue) in a retrospective cohort of 157 elderly patients with ICC. In addition, we sought to develop a comprehensive prognostic model to enhance risk stratification and improve clinical decision-making for this patient population.
A total of 528 ICC patients who underwent radical resection at Chongqing University Cancer Hospital (Chongqing, China) and West China Hospital (Chengdu, China) from 2009 to 2018 were retrospectively reviewed. Elderly patients were defined as those aged over 65 years. The exclusion criteria were as follows: preoperative radiofrequency ablation, transarterial chemoembolization, or other anti-cancer therapies; extrahepatic metastasis; patients underwent liver transplantation or surgical resection for tumor rupture; patients without imaging data. Patients who met the exclusion criteria were included in the analysis. The collected data included patient demographics, clinicopathological characteristics, preoperative computed tomography (CT) images, and disease status at the end of follow-up. This study was performed in accordance with the guidelines of the 1975 Declaration of Helsinki.
Surgical procedures were determined based on preoperative multidisciplinary discussions and intraoperative evaluations. Lymphadenectomy for ICC was performed according to the recommendations by Shimada et al. (13). The follow-up strategy was conducted in accordance with the National Comprehensive Cancer Network (NCCN) guidelines. In brief, the tumor marker carbohydrate antigen 19-9 (CA19-9) and imaging examinations (ultrasonography or CT) were performed monthly during the first 3 months, then every 3 months for 1 year, and subsequently every 6 months thereafter. For patients who were unable to return to the hospital for reexamination, telephone follow-up surveys were conducted to collect relevant clinical data. Overall survival (OS) was defined as the duration from the date of hepatic resection to death or the last follow-up. Recurrence-free survival (RFS) was defined as the period from the date of surgery to the first documented recurrence or the last follow-up.
As previously described (4), GNRI was calculated using the formula: GNRI = 14.89 × serum albumin (g/dL) + 41.7 × [present body weight (kg)/ideal body weight (kg)]. The ideal weight was calculated by 22 × [height (m)]2. Cross-sectional non-contrast plain CT images were applied for the assessment of body composition using Mimics software (version 21.0, Materialise NV, Leuven, Belgium). The measurements were validated by experienced radiologists. The areas of skeletal muscle and abdominal adipose tissue were determined at the level of the third lumbar vertebra. Skeletal muscle areas included the psoas, quadratus lumborum, erector spinae, transversus abdominis, and rectus abdominis. Tissue Hounsfield unit (HU) thresholds were used as previously reported (5): −29 to 150 HU for skeletal muscle, −150 to −50 for visceral adipose tissue, and −190 to −30 for subcutaneous adipose tissue. We termed the parameters for skeletal muscle as skeletal muscle index (SMI), visceral adipose tissue as visceral adipose tissue index (VATI), and subcutaneous adipose tissue as subcutaneous adipose tissue index (SATI), respectively. SMI was calculated as cross-sectional area of skeletal muscle (cm2)/height2 (m2). Visceral-to-subcutaneous adipose tissue area ratio (VSR) was calculated to determine abdominal adipose tissue distributions. In addition, muscle attenuation (MA) was applied for the assessment of skeletal muscle quality (14).
The continuous variable was expressed as mean ± standard deviation (SD) and analyzed using Student’s t-test or Wilcoxon rank sum test, depending on data distribution. Categorical variables were analyzed using the chi-square test or Fisher’s exact test, as appropriate. The optimal cutoff values for sex-specific GNRI and body composition variables were determined using receiver operating characteristic (ROC) curves, selecting the threshold at which the Youden index reached its maximum value. Kaplan–Meier (K–M) curves were plotted to illustrate cumulative mortality and recurrence, with differences tested using the log-rank test. Univariate and multivariate Cox proportional hazard models were used to identify independent prognostic indicators. Variables with a p-value of <0.05 in univariate analysis were included in the multivariate analysis. A prognostic nomogram was developed using independent prognostic factors identified through multivariate analysis, utilizing a backward stepwise selection method. The concordance index (C-index) and area under the curve (AUC) of time-dependent receiver operating characteristic (td-ROC) curves were used to compare the predictive performance of the nomogram and the conventional tumor-node-metastasis (TNM) staging system. The integrated AUC was calculated as the average AUC across different time points. Statistical analyses were performed by SPSS (version 23.0, Chicago, IL, United States), MedCalc (version 20.0.3.0, Ostend, Belgium), and R software (version 4.1.0).1 A two-sided p-value of <0.05 was considered statistically significant.
Among 528 ICC patients from a multi-institutional database, 157 met the inclusion criteria for this study (Supplementary Figure S1). The mean age was 70.1 years, and 74 patients (47.1%) were male. HBV infection was observed in 23 patients (14.6%), and 32 patients (20.4%) had hepatolithiasis. CA19-9 levels were within the normal range in 38 patients (24.2%). Regarding tumor characteristics, 122 patients (77.7%) presented with a solitary tumor, with a mean tumor size of 5.6 cm. The majority (116, 73.9%) were classified as TNM stage III.
The median BMI was 22 kg/m2 (IQR: 20.2–24.1). The median GNRI was 102.3 (IQR: 98.1–109.3) in males and 103.7 (IQR: 95.8–110.5) in females. The median SMI was 39.5 (IQR: 36.3–42.7) for males and 35.9 (IQR: 32.7–39.6) for females. Further baseline characteristics are provided in Table 1.
First, we examined the relationship between body mass index (BMI) and mortality in elderly intrahepatic cholangiocarcinoma (ICC) patients. Patients who survived had a higher BMI compared to those who did not (Figure 1A). However, Kaplan–Meier survival analysis revealed that underweight (BMI < 20 kg/m2), normal weight, and overweight (BMI > 24 kg/m2) patients had comparable overall survival (OS) and tumor relapse rates (Supplementary Figure S2). These findings suggest that BMI alone is not significantly associated with mortality in elderly ICC patients.
Figure 1. Body compositions quantified by cross-sectional computed tomography images of the third lumbar vertebra. (A) Violin plot shows BMI values in survival or death. (B) Distribution of GNRI values. (C) Violin plot shows GNRI values in survival or death. (D) Cross-sectional computed tomographic images at the level of the third lumbar vertebra among two patients with almost identical BMI (The red shadows represent the skeletal muscle areas, the green shadows represent the visceral adipose tissue areas, and the blue shadows represent the subcutaneous adipose tissue areas, respectively.). GNRI, geriatric nutritional risk index; SMI, skeletal muscle index; VATI, visceral adipose tissue index; SATI, subcutaneous adipose tissue index; MA, muscle attenuation.
Next, we analyzed the geriatric nutritional risk index (GNRI) and four indicators of body composition—skeletal muscle index (SMI), visceral adipose tissue index (VATI), subcutaneous adipose tissue index (SATI), and muscle attenuation (MA)—using cross-sectional non-contrast CT images. GNRI was significantly lower in deceased patients compared to survivors (Figures 1B,C). The optimal GNRI cutoff values were determined to be 107.3 for males and 108.2 for females. BMI showed only a weak correlation with GNRI (Supplementary Figure S3A). Moreover, SMI, visceral-to-subcutaneous fat ratio (VSR), and MA exhibited no clear correlation with BMI (Supplementary Figure S3B–D), indicating that BMI alone is not a reliable measure for assessing body composition. Notably, two patients with similar BMI values demonstrated substantial differences in body composition (Figure 1D). Further correlation analysis revealed that GNRI was moderately associated with SMI, VSR, and MA (Supplementary Figure S4).
Consistent with GNRI, gender-specific cutoff values were determined for these body composition parameters (Supplementary Figure S5). The cutoff values for SMI were 41.3 cm2/m2 in males and 37.2 cm2/m2 in females, those for VSR were 1.04 in males and 0.87 in females, and those for MA were 42.3 HU in males and 38.1 HU in females, respectively. Patients with low SMI were classified as having sarcopenia, those with high VSR as having visceral adiposity, and those with low MA as having intramuscular fat (IMF) deposition. Furthermore, we analyzed the association between these parameters and prognosis using Kaplan–Meier survival curves. Patients with low GNRI (n = 114) exhibited significantly higher mortality and earlier postoperative tumor relapse (Figures 2A,B). Similarly, patients with sarcopenia (n = 88), visceral adiposity (n = 86), and IMF deposition (n = 79) demonstrated shorter OS and recurrence-free survival (RFS) (Figures 3A–F). Collectively, these results indicate that both GNRI and body composition factors are prognostic indicators in elderly ICC patients following curative resection.
Figure 2. Kaplan–Meier curves showed overall and recurrence-free survival according to GNRI. (A) Overall survival rate after surgery classified by GNRI. (B) Recurrence-free survival rate after surgery classified by GNRI. GNRI, geriatric nutritional risk index.
Figure 3. Kaplan–Meier curves show overall and recurrence-free survival according to body composition variables. (A) Overall survival rate after surgery classified by SMI. (B) Recurrence-free survival rate after surgery classified by VSR. (C) Overall survival rate after surgery classified by GNRI. (D) Recurrence-free survival rate after surgery classified by VSR. (E) Overall survival rate after surgery classified by MA. (F) Recurrence-free survival rate after surgery classified by MA. SMI, skeletal muscle index; VSR, visceral-to-subcutaneous fat area ratio; MA, muscle attenuation.
Table 2 summarizes the clinicopathological characteristics of elderly ICC patients stratified by GNRI, sarcopenia, visceral adiposity, and IMF deposition. Notably, patients with low GNRI, sarcopenia, and IMF deposition had significantly larger tumor sizes. Moreover, perineural invasion and lymph node invasion were more frequently observed in patients with low GNRI and IMF deposition. Scatterplots demonstrated significant correlations among SMI, VSR, and MA (Figures 4A–C). Importantly, GNRI and these three body composition parameters collectively contributed to an increased risk of mortality and tumor recurrence in an additive manner (both p < 0.05, Figures 4D–E), suggesting that they serve as complementary prognostic markers for elderly ICC patients.
Table 2. Clinicopathological characteristics in 157 elderly ICC patients stratified by GNRI, SMI, VSR, and MA.
Figure 4. Body composition components served as complementary prognostic indicators for elderly ICC patients. (A–C) Correlation between SMI, VSR, and MA shows a significant correlation between them in both men and women. (D,E) Kaplan–Meier curves show a decreased overall survival rate and increased postoperative recurrence frequency based on the increase in the number of GNRI and body composition components. GNRI, geriatric nutritional risk index; SMI, skeletal muscle index; VSR, visceral-to-subcutaneous adipose tissue area ratio; MA, muscle attenuation.
Cox regression analyses were performed to identify independent risk factors associated with mortality and postoperative tumor recurrence (Table 3). Univariate analysis identified abnormal CA19-9 levels, poor tumor differentiation, perineural invasion, lymph node invasion, MVI, low GNRI, sarcopenia, visceral adiposity, and IMF deposition as potential predictors of poor OS and RFS. However, in multivariate analysis, tumor differentiation and perineural invasion were no longer significant prognostic factors. In contrast, abnormal CA19-9 levels, MVI, lymph node invasion, low GNRI, sarcopenia, visceral adiposity, and IMF deposition remained independent risk factors for poor prognosis in elderly ICC patients. In addition, multiple tumor number was identified as an independent risk factor for earlier tumor relapse.
Prognostic nomograms were developed based on the independent factors identified in the multivariate analysis. As shown in Figure 5A, the nomogram for OS achieved a C-index of 0.734 (95% CI: 0.697–0.773). The AUC values at 1, 3, and 5 years, along with the integrated AUC, were 0.805, 0.786, 0.843, and 0.809, respectively (Table 4). Calibration plots demonstrated strong concordance between the predicted and actual survival rates for OS (Figures 5B–D). Similarly, the nomogram for RFS showed a promising prognostic performance, with a C-index of 0.704 (95% CI: 0.669–0.739) (Figure 6A). The AUC values at 1, 3, and 5 years, along with the integrated AUC, were 0.786, 0.796, 0.832, and 0.815, respectively (Figures 6B–D). Since TNM staging is conventionally used to assess prognosis and guide treatment strategies for ICC patients, the predictive accuracy of the developed nomograms was compared to TNM staging using time-dependent ROC (td-ROC) analysis. The results demonstrated that the nomograms significantly outperformed TNM staging in prognostic prediction for both OS and RFS (Figures 5E, 6E). Collectively, the constructed nomograms, incorporating GNRI and body composition metrics, demonstrated superior prognostic efficiency compared to the TNM staging system, offering a more accurate tool for risk stratification in elderly ICC patients.
Figure 5. Establishment and validation of the prognostic nomogram for OS. (A) Nomogram was established using independent risk factors of OS. Each score was added up to obtain a total score. Patient 1 from this study was shown as an example (marked in red sign). (B–D) Calibration plots at 1-, 3-, and 5-year prediction showed the stabilization of the prognostic nomograms. (E) Time-dependent ROC compared the accuracy of the nomogram and AJCC-TNM stage in predicting OS showed better performance of the prognostic nomogram. OS, overall survival; AUC, area under the curve; ROC, receiver operating characteristic. GNRI, geriatric nutritional risk index; SMI, skeletal muscle index; VSR, visceral-to-subcutaneous adipose tissue area ratio; MA, muscle attenuation.
Figure 6. Establishment and validation of the prognostic nomogram for tumor relapse. (A) Nomogram was established using independent risk factors of RFS. Each score was added up to obtain a total score. Patient 1 from this study was shown as an example (marked in red sign). (B–D) Calibration plots at 1-, 3-, and 5-year prediction show the stabilization of the prognostic nomograms. (E) Time-dependent ROC compared the accuracy of nomogram and AJCC-TNM stage in predicting RFS showed better performance of the prognostic nomogram. RFS, recurrence-free survival; AUC, area under the curve; ROC, receiver operating characteristic. GNRI, geriatric nutritional risk index; SMI, skeletal muscle index; VSR, visceral-to-subcutaneous adipose tissue area ratio; MA, muscle attenuation.
Over the past two decades, the proportion of individuals aged over 65 has increased rapidly, accounting for approximately 10% of the global population. Aging is associated with a progressive decline in muscle mass, function, and quality, particularly among those aged 65 and older. In this study, we conducted a comprehensive evaluation of body composition and its impact on long-term survival in a large-scale retrospective cohort of 157 elderly ICC patients. Our findings demonstrated that low GNRI, sarcopenia, visceral adiposity, and IMF deposition serve as complementary risk factors for poor prognosis, with patients exhibiting these indicators experiencing significantly worse OS and RFS. Furthermore, we developed a prognostic nomogram based on independent risk factors and validated its strong predictive performance. Notably, our nomogram outperformed the conventional TNM staging system in prognostic assessment, providing a more accurate tool for risk stratification in elderly ICC patients.
Clinical estimation of body composition using conventional parameters, such as body weight, waist circumference, BMI, physical activity, and handgrip strength, remains challenging and is often compromised by a patient’s physical condition (5). In this study, we comprehensively analyzed the impact of GNRI combined with body composition on survival in a cohort of elderly ICC patients and identified skeletal muscle index (SMI), muscle attenuation (MA), and visceral-to-subcutaneous adipose tissue area ratio (VSR) as independent risk factors for poor prognosis. In addition, we examined the relationships among these body composition parameters and found that elderly ICC patients with a greater number of adverse body composition components had significantly worse survival outcomes.
A recent global cancer trend report highlighted that population aging contributed to the largest increase in cancer incidence, accounting for 56.5% (4.7 million) of cases and 63.3% (3.6 million) of deaths between 1990 and 2019 (15). According to our previous study, 26.1% of ICC patients who underwent curative resection were elderly (11). Older patients generally have a worse prognosis, particularly in cancer, due to their heightened vulnerability to malnutrition and immune dysfunction (16). Given these factors, GNRI and body composition parameters may serve as powerful prognostic indicators for ICC in elderly patients.
Malnutrition is prevalent in elderly patients, particularly those with malignancies (17). GNRI is an objective screening tool that predicts nutrition-related morbidity and mortality risks without the influence of underlying inflammatory processes (18). Since its introduction by Bouillanne in 2005, GNRI has been widely used to assess postoperative complications and overall survival in oncologic patients (19). A recent study by Riveros et al. confirmed that GNRI is a standardized nutritional screening tool capable of preoperatively assessing the risk of complications in elderly patients undergoing radical cystectomy (20). Consistent with our findings, low GNRI scores were significantly associated with worse survival outcomes in elderly ICC patients who underwent surgery.
Sarcopenia, a syndrome characterized by progressive declines in skeletal muscle mass (low SMI) and quality (low MA), can be classified as either primary or secondary (21). Primary sarcopenia results from age-related muscle loss, whereas secondary sarcopenia is linked to chronic diseases such as cancer and infections (10). Interestingly, Fujiwara et al. suggested that functional age, rather than chronological age, is more critical in determining prognosis in HCC patients, indicating that sarcopenia is not solely age-dependent but also influenced by metabolic status (5). Low muscle mass is associated with insulin resistance, systemic inflammation, and immune senescence, all of which contribute to tumor progression (22). In addition, muscle attenuation (myosteatosis) is characterized by inter- and intra-myocellular fat accumulation, which creates a pro-inflammatory microenvironment that weakens immune function via cytokines (23, 24). Myosteatosis has been linked to oxidative stress, reduced muscle function, and poor perioperative outcomes (25). Several studies have demonstrated that low muscle quality correlates with reduced muscle strength and poor survival outcomes in patients undergoing surgery for colorectal or head and neck cancer (26, 27). Similarly, we previously reported that low SMI is significantly associated with poor survival in ICC patients (11). Our current analysis further confirms that in elderly ICC patients, both low SMI and low MA negatively impact survival outcomes.
With aging, adipose tissue shifts from subcutaneous to visceral depots and ectopic sites, leading to altered metabolic and inflammatory profiles. Compared to subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) is more vascular, innervated, and metabolically active, with a higher number of inflammatory and immune cells. VAT is also more insulin-resistant and secretes adipokines that trigger hepatic immune activation, leading to inflammation. There are more glucocorticoid and androgen receptors in VAT than in SAT. VAT adipocytes are more metabolically active, more sensitive to lipolysis, and more insulin-resistant than SAT adipocytes (28). In addition, VAT venous blood is drained directly to the liver through the portal vein. This contrasts with SAT where venous drainage is through systemic veins. The portal drainage of visceral fat provides direct hepatic access to free fat acids and adipokines secreted by visceral adipocytes. Adipokines activate hepatic immune mechanisms with the production of inflammatory mediators such as C-reactive protein (28). These differences may explain how body fat distribution influences immune function, inflammation, and endocrine homeostasis, ultimately affecting disease prognosis. Numerous studies have reported that higher VAT levels are associated with impaired surgical outcomes and poor long-term survival (5). In this study, we identified a high visceral-to-subcutaneous adipose tissue area ratio (VSR) as a significant predictor of worse survival outcomes in elderly ICC patients.
Aging inevitably leads to declining muscle mass, impaired muscle function, and fat redistribution. Interestingly, myosteatosis can develop independently of muscle mass but may have a synergistic effect, exacerbating functional impairment. Recent evidence suggests that fat accumulation within muscle can negatively affect physiological responses, even in individuals with normal muscle mass (29). Despite these complexities, our study found a statistically significant relationship between muscle loss, fat redistribution, and poor prognosis in elderly ICC patients. At the molecular level, aging disrupts the balance between protein synthesis and proteolysis, as well as fat metabolism, further exacerbating malnutrition (30). These alterations create a vicious cycle, impairing muscle regeneration and accelerating muscle degradation (31). Accordingly, our findings confirm that elderly ICC patients with multiple adverse body composition parameters tend to have significantly worse survival outcomes. Our prognostic nomogram can assist in preoperative risk stratification, guiding patient selection for surgical resection or alternative treatments. High-risk patients, particularly those with low GNRI or sarcopenia, may benefit from prehabilitation strategies, such as nutritional interventions and resistance training, to improve surgical outcomes. In addition, these patients may require closer postoperative surveillance with more frequent imaging and tumor marker monitoring to detect early recurrence.
Despite its strengths, this study has several limitations. First, we focused only on elderly patients (aged 65 and older) with a relatively small sample size. While sarcopenia and visceral adiposity are more pronounced in elderly individuals due to age-related muscle loss and fat redistribution, metabolic and inflammatory changes related to poor body composition may also affect ICC prognosis in younger patients (15). Future studies should explore age-specific cutoffs for body composition parameters. In addition, incorporating machine learning and deep learning approaches could improve predictive accuracy in larger datasets. Second, as a retrospective study, some clinical data were incomplete, and patients without imaging data were excluded, potentially leading to selection bias. Moreover, while our study is based on multi-institutional data, variations in surgical techniques and postoperative management across centers may affect the generalizability of our findings. External validation in independent cohorts is essential to confirm these results.
The present study suggested that GNRI, sarcopenia, IMF deposition, and visceral adiposity independently predicted mortality and tumor recurrence in elderly ICC patients following curative liver resection. Body composition was a major determinant of prognosis in patients with ICC. Furthermore, we established a prognostic nomogram based on GNRI and body composition revealed superior prognostic efficacy over conventional TNM stages. In the future, interventions targeting body composition, such as exercise therapy, nutritional support, and even the use of drugs to prevent muscle depletion, may be effective in improving the long-term survival of ICC patients, especially for the elderly.
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.
The studies involving humans were approved by Institutional Review Board of Chongqing University Cancer Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
SW: Data curation, Formal analysis, Writing – original draft, Writing – review & editing. LC: Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing. LD: Data curation, Formal analysis, Methodology, Software, Writing – original draft, Writing – review & editing. YK: Methodology, Software, Writing – original draft, Writing – review & editing. YH: Data curation, Formal analysis, Writing – original draft, Writing – review & editing. TW: Methodology, Writing – original draft, Writing – review & editing. LX: Software, Writing – original draft, Writing – review & editing. WX: Software, Writing – original draft, Writing – review & editing. CZ: Methodology, Writing – original draft, Writing – review & editing. DL: Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing. HL: Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Writing – original draft, Writing – review & editing.
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the National Natural Science Foundation of China (82203823), the Natural Science Foundation of Chongqing (CSTB2022NSCQ-MSX0477, CSTB2022NSCQ-MSX1174, CSTB2024NSCQ-QCXMX0051), and the Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau) (2024ZDXM008).
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors declare that no Gen AI was used in the creation of this manuscript.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2025.1565317/full#supplementary-material
SUPPLEMENTARY FIGURE S1 | Flow diagram showing study design. The multi-institutional dataset was went through to include patients. A total of 157 elderly patients passed the exclusion criteria were identified.
SUPPLEMENTARY FIGURE S2 | Kaplan-Meier curves showed overall survival (A) and recurrence-free survival (B) according to BMI. BMI was classified as less than was classified as underweight (<20kg/m2), normal weight, and overweight (> 24kg/m2). BMI, body mass index. P value was determined by log-rank analysis.
SUPPLEMENTARY FIGURE S3 | The correlations between BMI and GNRI (A), SMI (B), VSR (C), MA (D). BMI was weakly correlated to GNRI, although statistically significant. BMI, body mass index; GNRI, geriatric nutritional risk index; SMI, skeletal muscle index; VSR, visceral to subcutaneous adipose tissue area ratio; MA, muscle attenuation.
SUPPLEMENTARY FIGURE S4 | The correlations between GNRI and SMI (A), VSR (B), MA (C) were statistically significant. GNRI, geriatric nutritional risk index; SMI, skeletal muscle index; VSR, visceral to subcutaneous adipose tissue area ratio; MA, muscle attenuation.
SUPPLEMENTARY FIGURE S5 | Definitions and classifications of the GNRI and prognostic body composition components. The stratification was based on gender. GNRI, geriatric nutritional risk index; SMI, skeletal muscle index; VSR, visceral to subcutaneous adipose tissue area ratio; MA, muscle attenuation.
1. Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2021) 71:209–49. doi: 10.3322/caac.21660
2. Li, H, Lan, T, Liu, H, Liu, C, Dai, J, Xu, L, et al. IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md). (2022) 75:1402–19. doi: 10.1002/hep.32232
3. Rich, NE, Yopp, AC, Singal, AG, and Murphy, CC. Hepatocellular carcinoma incidence is decreasing among younger adults in the United States. Clin Gastroenterol Hepatol. (2020) 18:242–248.e5. doi: 10.1016/j.cgh.2019.04.043
4. Ruan, GT, Zhang, Q, Zhang, X, Tang, M, Song, MM, Zhang, XW, et al. Geriatric nutrition risk index: prognostic factor related to inflammation in elderly patients with cancer cachexia. J Cachexia Sarcopenia Muscle. (2021) 12:1969–82. doi: 10.1002/jcsm.12800
5. Fujiwara, N, Nakagawa, H, Kudo, Y, Tateishi, R, Taguri, M, Watadani, T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. (2015) 63:131–40. doi: 10.1016/j.jhep.2015.02.031
6. Hakimi, AA, Furberg, H, Zabor, EC, Jacobsen, A, Schultz, N, Ciriello, G, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst. (2013) 105:1862–70. doi: 10.1093/jnci/djt310
7. Casirati, A, Vandoni, G, Della Valle, S, Greco, G, Platania, M, Colatruglio, S, et al. Nutritional status and body composition assessment in patients with a new diagnosis of advanced solid tumour: exploratory comparison of computed tomography and bioelectrical impedance analysis. Clin Nutr (Edinburgh, Scotland). (2021) 40:1268–73. doi: 10.1016/j.clnu.2020.08.009
8. Sargento, L, Vicente Simões, A, Rodrigues, J, Longo, S, Lousada, N, and Palma Dos Reis, R. Geriatric nutritional risk index as a nutritional and survival risk assessment tool in stable outpatients with systolic heart failure. Nutr Metab Cardiovasc Dis. (2017) 27:430–7. doi: 10.1016/j.numecd.2017.02.003
9. Rosenberg, IH, and Roubenoff, R. Stalking sarcopenia. Ann Intern Med. (1995) 123:727–8. doi: 10.7326/0003-4819-123-9-199511010-00014
10. Cruz-Jentoft, AJ, Baeyens, JP, Bauer, JM, Boirie, Y, Cederholm, T, Landi, F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. (2010) 39:412–23. doi: 10.1093/ageing/afq034
11. Li, H, Dai, J, Lan, T, Liu, H, Wang, J, Cai, B, et al. Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection. Clin Nutr (Edinburgh, Scotland). (2021) 40:3891–900. doi: 10.1016/j.clnu.2021.04.038
12. Li, CW, Yu, K, Shyh-Chang, N, Jiang, Z, Liu, T, Ma, S, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. (2022) 13:781–94. doi: 10.1002/jcsm.12901
13. Shimada, M, Yamashita, Y, Aishima, S, Shirabe, K, Takenaka, K, and Sugimachi, K. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. (2001) 88:1463–6. doi: 10.1046/j.0007-1323.2001.01879.x
14. Martin, L, Birdsell, L, Macdonald, N, Reiman, T, Clandinin, MT, LJ, MC, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. (2013) 31:1539–47. doi: 10.1200/JCO.2012.45.2722
15. Ju, W, Zheng, R, Wang, S, Zhang, S, Zeng, H, Chen, R, et al. The occurence of cancer in ageing populations at global and regional levels, 1990 to 2019. Age Ageing. (2023) 52:afad043. doi: 10.1093/ageing/afad043
16. Bourke, CD, Berkley, JA, and Prendergast, AJ. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol. (2016) 37:386–98. doi: 10.1016/j.it.2016.04.003
17. Zhang, X, and Edwards, BJ. Malnutrition in older adults with cancer. Curr Oncol Rep. (2019) 21:80. doi: 10.1007/s11912-019-0829-8
18. Saghafi-Asl, M, Vaghef-Mehrabany, E, Karamzad, N, Daeiefarshbaf, L, Kalejahi, P, and Asghari-Jafarabadi, M. Geriatric nutritional risk index as a simple tool for assessment of malnutrition among geriatrics in northwest of Iran: comparison with mini nutritional assessment. Aging Clin Exp Res. (2018) 30:1117–25. doi: 10.1007/s40520-018-0892-2
19. Nakayama, M, Gosho, M, Adachi, M, Ii, R, Matsumoto, S, Miyamoto, H, et al. The geriatric nutritional risk index as a prognostic factor in patients with advanced head and neck cancer. Laryngoscope. (2021) 131:E151–e156. doi: 10.1002/lary.28587
20. Riveros, C, Jazayeri, SB, Chalfant, V, Ahmed, F, Bandyk, M, and Balaji, KC. The geriatric nutritional risk index predicts postoperative outcomes in bladder cancer: a propensity score-matched analysis. J Urol. (2022) 207:797–804. doi: 10.1097/JU.0000000000002342
21. Zeng, X, Shi, ZW, Yu, JJ, Wang, LF, Luo, YY, Jin, SM, et al. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle. (2021) 12:1948–58. doi: 10.1002/jcsm.12797
22. Kelley, DE, Goodpaster, BH, and Storlien, L. Muscle triglyceride and insulin resistance. Annu Rev Nutr. (2002) 22:325–46. doi: 10.1146/annurev.nutr.22.010402.102912
23. Czigany, Z, Kramp, W, Lurje, I, Miller, H, Bednarsch, J, Lang, SA, et al. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation. J Cachexia Sarcopenia Muscle. (2021) 12:358–67. doi: 10.1002/jcsm.12669
24. Hamaguchi, Y, Kaido, T, Okumura, S, Kobayashi, A, Shirai, H, Yao, S, et al. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. J Cachexia Sarcopenia Muscle. (2018) 9:246–54. doi: 10.1002/jcsm.12276
25. Nachit, M, and Leclercq, IA. Emerging awareness on the importance of skeletal muscle in liver diseases: time to dig deeper into mechanisms! Clin Sci (Lond). (2019) 133:465–81. doi: 10.1042/CS20180421
26. Ahern, E, Brown, TE, Campbell, L, BGM, H, Banks, M, Lin, CY, et al. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment. Br J Nutr. (2023) 129:406–15. doi: 10.1017/S0007114522000435
27. Koh, HH, Cho, ES, Lee, JH, Shin, SJ, Lee, HS, Park, EJ, et al. Association of Albumin-Bilirubin Grade and myosteatosis with its prognostic significance for patients with colorectal cancer. Ann Surg Oncol. (2022) 29:3868–76. doi: 10.1245/s10434-022-11445-z
28. Ibrahim, MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. (2010) 11:11–8. doi: 10.1111/j.1467-789X.2009.00623.x
29. van der Kroft, G, van Dijk, DPJ, Rensen, SS, van Tiel, FH, de Greef, B, West, M, et al. Low thoracic muscle radiation attenuation is associated with postoperative pneumonia following partial hepatectomy for colorectal metastasis. HPB (Oxford). (2020) 22:1011–9. doi: 10.1016/j.hpb.2019.10.1532
30. Tardif, N, Salles, J, Guillet, C, Tordjman, J, Reggio, S, Landrier, JF, et al. Muscle ectopic fat deposition contributes to anabolic resistance in obese sarcopenic old rats through eIF2α activation. Aging Cell. (2014) 13:1001–11. doi: 10.1111/acel.12263
Keywords: intrahepatic cholangiocarcinoma, elderly patient, geriatric nutritional risk index, body composition, malnutrition
Citation: Wang S, Cheng L, Dou L, Kuang Y, Huang Y, Wen T, Xiang L, Xie W, Zhang C, Li D and Li H (2025) Geriatric nutritional risk index and body composition dictate the prognosis of elderly patients with intrahepatic cholangiocarcinoma. Front. Nutr. 12:1565317. doi: 10.3389/fnut.2025.1565317
Received: 23 January 2025; Accepted: 20 February 2025;
Published: 07 March 2025.
Edited by:
Jiang Zhong, Loma Linda University, United StatesReviewed by:
Jun Liu, Shandong Provincial Hospital, ChinaCopyright © 2025 Wang, Cheng, Dou, Kuang, Huang, Wen, Xiang, Xie, Zhang, Li and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Dewei Li, bGlkZXdlaTQwNkBzaW5hLmNvbQ==; Hui Li, bGloQGNxdS5lZHUuY24=
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.